type here...

CATEGORIES

Editors Choice

LATEST

1234...155Page 3 of 155

TRENDING

EDITORS CHOICE

CAR T-mRNA Therapy For Cardiac Fibrosis: A New Way Forward

William Haseltine, PhD -
This is a series on the advances in CAR T, a remarkable immunotherapy treatment dubbed a “living drug.” This new therapy genetically modifies a patient’s cells to fight cancer, but current research efforts hope to treat autoimmune diseases, organ damage and more.

Who Will Direct Patient Care: Physicians or Technocrats?

Gil Bashe, Medika Life Editor -
Not long ago, a physician’s most powerful instrument was not a machine, an algorithm, or a digital platform. It was presence. Listening with intention....

Could Covid Silently Benefit Us by Providing a Cure for Influenza?

Robert Turner, Founding Editor -
The similarities found between SARS-CoV-2 and SARS-CoV, MERS-CoV, or human immunodeficiency viruses (HIV) can enhance the development of potential therapeutic approaches and advance the understanding of the virus mechanism of action -

Stop Owning a Cancer Diagnosis

Christina Vaughn -
Sitting on hold on the phone a few years ago during active cancer treatment to speak to one of my Texas Oncology providers, I...

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories